Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) for people with psoriatic arthritis in remission or low disease activity.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE
    • Publication Information:
      Publication: 2004- : Chichester, West Sussex, England : Wiley
      Original Publication: Oxford, U.K. ; Vista, CA : Update Software,
    • Subject Terms:
      Antirheumatic Agents*/therapeutic use ; Antirheumatic Agents*/administration & dosage ; Arthritis, Psoriatic*/drug therapy ; Biological Products*/therapeutic use ; Biological Products*/administration & dosage; Humans ; Drug Tapering ; Randomized Controlled Trials as Topic ; Remission Induction ; Withholding Treatment ; Review Literature as Topic
    • Abstract:
      Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the benefits and harms of dose reduction or discontinuation of biologic disease-modifying anti-rheumatic drugs or targeted synthetic disease-modifying anti-rheumatic drugs in adults with psoriatic arthritis who are in remission or a low disease activity state.
      (Copyright © 2024 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.)
    • References:
      J Health Commun. 2010;15 Suppl 2:211-23. (PMID: 20845205)
      Clin Cosmet Investig Dermatol. 2015 Nov 04;8:563-9. (PMID: 26622188)
      RMD Open. 2022 Mar;8(1):. (PMID: 35321874)
      BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
      Arthritis Rheum. 1971 Nov-Dec;14(6):706-20. (PMID: 5135791)
      Arthritis Res Ther. 2005;7(4):R796-806. (PMID: 15987481)
      Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii14-7. (PMID: 15708927)
      Arthritis Rheum. 2006 Aug;54(8):2665-73. (PMID: 16871531)
      N Engl J Med. 2017 Mar 9;376(10):957-970. (PMID: 28273019)
      J Rheumatol. 2023 Nov;50(Suppl 2):53-57. (PMID: 37419621)
      Br J Dermatol. 2003 Aug;149(2):323-31. (PMID: 12932239)
      Lancet. 2015 Jul 18;386(9990):258-65. (PMID: 25975452)
      Arthritis Rheum. 2012 Oct;64(10):3150-5. (PMID: 22576997)
      Ann Rheum Dis. 2020 Jun;79(6):700-712. (PMID: 32434812)
      Intern Med J. 2020 Jan;50(1):17-23. (PMID: 30548385)
      Br J Rheumatol. 1991 Aug;30(4):245-50. (PMID: 1863819)
      Arthritis Rheum. 1980 Feb;23(2):137-45. (PMID: 7362664)
      J Rheumatol. 2016 Feb;43(2):371-5. (PMID: 26669918)
      Cochrane Database Syst Rev. 2019 May 24;5:CD010455. (PMID: 31125448)
      Ann Rheum Dis. 2020 Jun;79(6):778-786. (PMID: 32381564)
      Clin Exp Rheumatol. 2012 Mar-Apr;30(2):282-9. (PMID: 22339882)
      J Clin Epidemiol. 2014 Jan;67(1):56-64. (PMID: 24189091)
      J Rheumatol. 2007 May;34(5):1167-70. (PMID: 17477480)
      RMD Open. 2020 Feb;6(1):. (PMID: 32094304)
      Semin Arthritis Rheum. 2019 Dec;49(3):381-388. (PMID: 31272807)
      J Am Acad Dermatol. 2019 Jan;80(1):251-265.e19. (PMID: 29928910)
      Arthritis Care Res (Hoboken). 2016 Sep;68(9):1320-31. (PMID: 26713432)
      J Rheumatol. 2014 Feb;41(2):194-205. (PMID: 24293581)
      Intern Med J. 2022 Oct;52(10):1799-1805. (PMID: 35567366)
      Z Rheumatol. 2001 Jun;60(3):156-66. (PMID: 11475603)
      J Clin Epidemiol. 2013 Feb;66(2):173-83. (PMID: 23116689)
      Q J Med. 1987 Feb;62(238):127-41. (PMID: 3659255)
      J Rheumatol. 2014 Aug;41(8):1670-4. (PMID: 25028377)
      Semin Arthritis Rheum. 1973;3(1):55-78. (PMID: 4581554)
      BMC Public Health. 2013 Jul 16;13:658. (PMID: 23855504)
      Best Pract Res Clin Rheumatol. 2012 Feb;26(1):147-56. (PMID: 22424200)
      Med Care. 1992 Jun;30(6):473-83. (PMID: 1593914)
      Arthritis Care Res (Hoboken). 2011 Jan;63(1):39-52. (PMID: 20842715)
      J Clin Epidemiol. 2017 Nov;91:23-30. (PMID: 28912002)
      J Rheumatol. 1997 Mar;24(3):511-7. (PMID: 9058658)
      Arthritis Rheumatol. 2019 Feb;71(2):258-270. (PMID: 30225992)
      Acta Derm Venereol. 2002;82(2):108-13. (PMID: 12125937)
      Gut. 2012 Dec;61(12):1693-700. (PMID: 22595313)
      Health Policy. 1990 Dec;16(3):199-208. (PMID: 10109801)
      Arthritis Rheum. 1995 Jan;38(1):44-8. (PMID: 7818570)
      Semin Arthritis Rheum. 2018 Aug;48(1):28-34. (PMID: 29398124)
    • Accession Number:
      0 (Antirheumatic Agents)
      0 (Biological Products)
    • Publication Date:
      Date Created: 20241216 Date Completed: 20241216 Latest Revision: 20250104
    • Publication Date:
      20250104
    • Accession Number:
      PMC11648595
    • Accession Number:
      10.1002/14651858.CD015880
    • Accession Number:
      39679815